DERM

Journey Medical Corporation

7.91 USD

Last updated Sep 4, 20:50 UTC

Yesterday HIGH

$7.97

Yesterday LOW

$7.74

52w HIGH

$9.55

52w LOW

$4.31

EPS

-0.01

PE

-791.00

Next Earnings

Nov 11, 2026

Overview News Government Trades Fundamentals

Journey Medical Corporation stock is up 23.59% since 30 days ago. The next earnings date is Nov 11, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 September’s closed higher than August. 100% of analysts rate it a buy.

Benzinga Newsdesk

Thu Aug 13, 2026

B. Riley Securities Reiterates Buy on Journey Medical, Raises Price Target to $15

B. Riley Securities analyst Mayank Mamtani reiterates Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $12 to $15.
Benzinga Insights

Thu Aug 13, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares increased by
Benzinga Newsdesk

Wed Aug 12, 2026

Journey Medical Q2 EPS $(0.01) Beats $(0.02) Estimate, Sales $17.839M Miss $18.366M Estimate

Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 93.75 percent increase over losses of $(0.16) per share from the
Benzinga Newsdesk

Thu May 14, 2026

Journey Medical shares are trading higher after the company reported better-than-expected Q1 sales results.
Benzinga Insights

Wed May 13, 2026

Transcript: Journey Medical Q1 2026 Earnings Conference Call
Benzinga Newsdesk

Wed May 13, 2026

Journey Medical Q1 EPS $(0.08), Inline, Sales $15.961M Beat $15.948M Estimate

Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 55.56 percent increase over losses of $(0.18) per share from the same period last year.
Benzinga Insights

Wed May 13, 2026

Earnings Scheduled For May 13, 2026
Benzinga Newsdesk

Tue Apr 21, 2026

Fortress Biotech Subsidiary Journey Medical Expands U.S. Market Access For Emrosi Following Third Group Purchasing Contract